Subscribe to Email Updates

    Med Tech Innovation | 1 min read

    LaunchPad Company, Innoture, Starts Research for COVID Vaccine

    UK firm starts research on skin patch for COVID vaccines

    Originally from

    Innoture has received funding from the Welsh Government to start proof-of-concept research into the use of its next-generation microneedle skin patch for the self-administration of COVID-19 and other vaccines.

    Innoture has been awarded a grant of almost £200,000 from the Welsh Government via SMARTCymru 2014-2020 European Regional Development Fund West Wales and the Valleys to fund a research project entitled 'Self-Administration of SARS-CoV-2 Vaccine via Microlithographic 3D printed Microstructure Patches'.

    The group is now testing the patch's ability to deliver a vaccine dose via the skin at its laboratories in the Institute of Life Science (ILS2) at Swansea University in Wales.

    Dr Michael Graz, chief scientific officer of Innoture, said: “In the wake of the coronavirus pandemic, vaccine developers and manufacturers face a major challenge to rapidly develop and upscale their vaccination programmes as the demand for needles, glass vials plus other treatment delivery supplies, increases. Therefore, it is vital that alternative delivery options are considered by the UK – and international – health community.”

    He added: “Our transdermal delivery system has the potential to improve patient experience and significantly reduce the burden on the NHS and other healthcare systems.

    Read the full article here

    Related Categories

    Med Tech Innovation

    Let Us Know What You Thought about this Post.

    Put your Comment Below.

    You may also like:

    Events Med Tech

    Politically Incorrect Diversity in Clinical Trials

    Read the full article on

    Med Tech Start Up Octane News

    LaunchPad Announces Top 8 Presenting Companies at MedTech Innovation Forum 2021

    September 29, 2021, Aliso Viejo, CA. Octane, Southern California's leading accelerator announced today the top 8 LaunchP...

    Events Med Tech

    Octane CEO: ‘We must not become complacent’ on innovation

    Original article can be found on